**EXHIBIT
      31.1**





**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**PURSUANT
      TO 18 U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO SECTION 302 OF**


**THE
      SARBANES-OXLEY ACT OF 2002**




I,
      Dr.
      David F. Hostelley, certify that:




1.
      I have
      reviewed this quarterly report for the period ending September 30, 2006 on
      Form
      10-QSB of Organetix, Inc.;




2.
      Based
      on my knowledge, this quarterly report does not contain any untrue statement
      of
      a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were
      made, not misleading with respect to the period covered by this quarterly
      report;




3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this quarterly report, fairly present in all material respects
      the
      financial condition, results of operations and cash flows of the registrant
      as
      of, and for, the periods presented in this quarterly report;




4.
      I am
      responsible for establishing and maintaining disclosure controls and procedures
      (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
      have:




a)
      designed such disclosure controls and procedures to ensure that material
      information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the
      period in which this quarterly report is being prepared;




b)
      evaluated the effectiveness of the registrant's disclosure controls and
      procedures as of a date within 90 days prior to the filing date of this
      quarterly report (the "Evaluation Date"); and




c)
      presented in this quarterly report my conclusions about the effectiveness of
      the
      disclosure controls and procedures based on our evaluation as of the Evaluation
      Date;




5.
      I have
      disclosed, based on our most recent evaluation, to the registrant's auditors
      and
      the audit committee of registrant's board of directors (or persons performing
      the equivalent functions):




a)
      all
      significant deficiencies in the design or operation of internal controls which
      could adversely affect the registrant's ability to record, process, summarize
      and report financial data and have identified for the registrant's auditors
      any
      material weaknesses in internal controls; and




b)
      any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the registrant's internal controls; and




6.
      I have
      indicated in this quarterly report whether or not there were significant changes
      in internal controls or in other factors that could significantly affect
      internal controls subsequent to the date of my most recent evaluation, including
      any corrective actions with regard to significant deficiencies and material
      weaknesses.








Date:
      November 20, 2006








/s/
      Dr. David F. Hostelley


Name:
      Dr.
      David F. Hostelley


Title:
      Chief Executive Officer